Ligand Pharmaceuticals Incorporated
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ligand Pharmaceuticals Incorporated's balance sheet done over the years? Its assets were worth $787,216,000 last year, which is more than in the previous period. 11% of Ligand Pharmaceuticals Incorporated’s total assets is currently financed by debt. Its liabilities reached the amount of $86,303,000, which means an decrease by -48% compared compared to last year.
Debt to Assets
| 2014 | 258029000 | 233.62M | 90.54% |
|---|---|---|---|
| 2015 | 533929000 | 229.53M | 42.99% |
| 2016 | 601585000 | 230.73M | 38.35% |
| 2017 | 671021000 | 252.37M | 37.61% |
| 2018 | 1260803000 | 699.88M | 55.51% |
| 2019 | 1469307000 | 702.07M | 47.78% |
| 2020 | 1362285000 | 652.76M | 47.92% |
| 2021 | 1301383000 | 479.75M | 36.86% |
| 2022 | 762668000 | 165.18M | 21.66% |
| 2023 | 787216000 | 86.30M | 10.96% |
LGND Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 22.95M | 45.00K | 19.52M | 47.61M | 1.01B | 718.38M | 201.66M | 141.04M | 200.21M | 167.33M |
Short term investments | 147.35M | 166.86K | 321.58M | 363.56M | 58.33M | 46.19M | 181.04M | 122.29M | 102.79M | 7.13M |
Net receivables | 39.31M | 35.03M | 91.64M | 59.06M | 41.74M | 55.85M | 25.59M | 17.90M | 11.68M | 12.63M |
Inventory | 23.96M | 13.29M | 27.32M | 26.48M | 7.29M | 7.12M | 4.37M | 1.92M | 1.63M | 269K |
Other current assets | 3.83M | 3.39M | 4.67M | 3.82M | 4.73M | 20.41M | 5.39M | 2.17M | 1.17M | 4.91M |
Total current assets | 237.42M | 263.60M | 464.75M | 500.55M | 1.12B | 870.54M | 237.02M | 163.05M | 215.57M | 185.15M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 25.06M | 15.00M | 32.74M | 22.73M | 10.35M | 5.37M | 4.21M | 1.81M | 372K | 486K |
Goodwill | 103.37M | 448.12M | 734.99M | 784.99M | 305.67M | 306.43M | 314.54M | 276.91M | 60.58M | 62.96M |
Intangible assets | 366.89M | 10.18M | 10.11M | 10.97M | 20.09M | 31.46M | 19.52M | 25.82M | 8.55M | 4.56M |
Long term investments | 48.32M | 3M | 0 | 0 | -25.60M | 601.21M | 6.43M | 8.34M | 29.72M | -257K |
Other non-current assets | 5.92M | 14.21M | 23.25M | 18.70M | 9.54M | -600.74M | 4.85M | 1.74M | 2.55M | 4.85M |
Total non-current assets | 549.78M | 499.06M | 836.63M | 861.72M | 345.66M | 390.26M | 434M | 438.53M | 318.35M | 72.87M |
Total assets | 787.21M | 762.66M | 1.30B | 1.36B | 1.46B | 1.26B | 671.02M | 601.58M | 533.92M | 258.02M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 1.22M | 355K | 10.99M | 29.43M | 2.13M | 3.28M | 173K | 0 | -934K | 150K |
Short term debt | 410K | 77.41M | 46K | 6.59M | 1.24M | 26.43M | 227.64M | 212.91M | 201.98M | 334K |
Total current liabilities | 16.78M | 98.81M | 41.66M | 100.11M | 17.00M | 82.24M | 238.86M | 227.12M | 20.83M | 22.77M |
| Non-current liabilities: | ||||||||||
Long term debt | 5.75M | 10.33M | 336.21M | 447.93M | 648.92M | 609.86M | 18.85M | 29.56M | 205.37M | 195.90M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 62.32M | -5.19M | 39.45M | 40.11M | 28.81M | 7.77M | -8.87M | -26.31M | 3.33M | 10.05M |
Total non-current liabilities | 69.52M | 66.37M | 438.08M | 552.64M | 685.07M | 617.64M | 13.50M | 3.60M | 208.70M | 210.84M |
Total liabilities | 86.30M | 165.18M | 479.75M | 652.76M | 702.07M | 699.88M | 252.37M | 230.73M | 229.53M | 233.62M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |